Sign up to save your podcasts
Or
Share CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Robin Foà, Filippo Milano and Rahul Banerjee
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Robin Foà, Filippo Milano and Rahul Banerjee
In this episode of Hematology Pills, Professor Robin Foà speaks with Dr. Filippo Milano and Dr. Rahul Banerjee about the current role of CAR-T cell therapy in the treatment of multiple myeloma. The discussion touches on key aspects such as therapeutic potential, toxicity management, and the practical issues related to access. Aimed at clinicians and healthcare professionals, the episode provides a clear overview of both opportunities and limitations of this evolving approach.
View all episodes
By Mattioli HealthIn this episode of Hematology Pills, Professor Robin Foà speaks with Dr. Filippo Milano and Dr. Rahul Banerjee about the current role of CAR-T cell therapy in the treatment of multiple myeloma. The discussion touches on key aspects such as therapeutic potential, toxicity management, and the practical issues related to access. Aimed at clinicians and healthcare professionals, the episode provides a clear overview of both opportunities and limitations of this evolving approach.